Aplenzin 174 mg/1 (Bupropion Hydrobromide TABLET, EXTENDED RELEASE) 174 mg/1

Aplenzin 174 mg is an extended-release tablet containing bupropion hydrobromide, used to manage depression and seasonal affective disorder. This medication is designed for oral administration and is manufactured by Bausch Health US, LLC.

Strength

174 mg/1

Pack Size

30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-5810-30)

Manufacturer / TM Owner

Bausch Health US, LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Aplenzin 174 mg is primarily used for the management of major depressive disorder (MDD) and seasonal affective disorder (SAD). Bupropion hydrobromide, the active ingredient, is a type of antidepressant that works by affecting certain chemicals in the brain. People often ask, 'What is Aplenzin used for?' and the answer is that it is typically prescribed to help alleviate symptoms of depression and improve mood.

Side Effects

Common effects of Aplenzin 174 mg may include dry mouth, nausea, dizziness, and insomnia. Some users might experience headaches or constipation. These effects can vary from person to person and are not experienced by everyone who takes the medication.

Precautions & Warnings

Aplenzin 174 mg should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication should be stored at room temperature and kept out of reach of children. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Avoid Interactions

Aplenzin 174 mg may interact with other medications, including those that affect the central nervous system. It is advisable to avoid alcohol while taking this medication, as it can increase the risk of side effects. Always consult with a healthcare professional before starting or stopping any medication.

Frequently Asked Questions

Aplenzin 174 mg is used to manage major depressive disorder (MDD) and seasonal affective disorder (SAD).

Aplenzin 174 mg is an extended-release tablet designed for oral administration. Follow the dosage instructions provided by your healthcare professional.

Common side effects may include dry mouth, nausea, dizziness, and insomnia. Always consult a healthcare professional for personalized advice.

Aplenzin 174 mg may interact with other medications, especially those that affect the central nervous system. Consult a healthcare professional before combining medications.

It is advisable to avoid alcohol while taking Aplenzin 174 mg, as it can increase the risk of side effects.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.